ImmunoGen Inc (NASDAQ:IMGN)

8.98
Delayed Data
As of May 29
 -0.04 / -0.44%
Today’s Change
5.34
Today|||52-Week Range
13.78
+47.21%
Year-to-Date
No recent news for ImmunoGen Inc.

Today’s Trading

Previous close9.02
Today’s open9.01
Day’s range8.93 - 9.17
Volume624,070
Average volume (3 months)1,512,173
Market cap$777.4M
Dividend yield--
Data as of 4:00pm ET, 05/29/2015

Growth & Valuation

Earnings growth (last year)+4.60%
Earnings growth (this year)+19.22%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+68.55%
P/E ratioNM
Price/Sales8.71
Price/Book10.24

Competitors

 Today’s
change
Today’s
% change
BCRXBioCryst Pharmaceuti...+0.04+0.36%
BPMCBlueprint Medicines ...+0.14+0.49%
OVASOvaScience Inc+3.01+9.73%
OSIROsiris Therapeutics ...-0.08-0.43%
Data as of 4:14pm ET, 05/29/2015

Financials

Next reporting dateJuly 31, 2015
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$59.9M
Annual profit (last year)-$71.4M
Net profit margin-119.15%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel M. Junius
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers